293 related articles for article (PubMed ID: 17888740)
1. Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG.
Borsuk S; Mendum TA; Fagundes MQ; Michelon M; Cunha CW; McFadden J; Dellagostin OA
Tuberculosis (Edinb); 2007 Nov; 87(6):474-80. PubMed ID: 17888740
[TBL] [Abstract][Full Text] [Related]
2. Stable expression of Leptospira interrogans antigens in auxotrophic Mycobacterium bovis BCG.
Seixas FK; Borsuk S; Fagundes MQ; Hartwig DD; Da Silva EF; Cerqueira GM; Dellagostin OA
Biol Res; 2010; 43(1):13-8. PubMed ID: 21157628
[TBL] [Abstract][Full Text] [Related]
3. New use of BCG for recombinant vaccines.
Stover CK; de la Cruz VF; Fuerst TR; Burlein JE; Benson LA; Bennett LT; Bansal GP; Young JF; Lee MH; Hatfull GF
Nature; 1991 Jun; 351(6326):456-60. PubMed ID: 1904554
[TBL] [Abstract][Full Text] [Related]
4. Stable expression of Mycobacterium bovis antigen 85B in auxotrophic M. bovis bacillus Calmette-Guérin.
Rizzi C; Peiter AC; Oliveira TL; Seixas AC; Leal KS; Hartwig DD; Seixas FK; Borsuk S; Dellagostin OA
Mem Inst Oswaldo Cruz; 2017 Feb; 112(2):123-130. PubMed ID: 28177046
[TBL] [Abstract][Full Text] [Related]
5. Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines.
DasGupta SK; Jain S; Kaushal D; Tyagi AK
Biochem Biophys Res Commun; 1998 May; 246(3):797-804. PubMed ID: 9618292
[TBL] [Abstract][Full Text] [Related]
6. Transformation of BCG with plasmid DNA.
Lugosi L; Jacobs W; Bloom BR
Acta Leprol; 1989; 7 Suppl 1():256-7. PubMed ID: 2503999
[TBL] [Abstract][Full Text] [Related]
7. Preclinical development of BCG.HIVA
Mahant A; Saubi N; Eto Y; Guitart N; Gatell JM; Hanke T; Joseph J
Hum Vaccin Immunother; 2017 Aug; 13(8):1798-1810. PubMed ID: 28426273
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Mycobacterium bovis BCG.
Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of live recombinant BCG vaccines.
Hanson MS; Bansal GP; Langermann S; Stover CK; Orme I
Dev Biol Stand; 1995; 84():229-36. PubMed ID: 7796958
[TBL] [Abstract][Full Text] [Related]
10. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK
Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571
[TBL] [Abstract][Full Text] [Related]
11. Generation of recombinant bacillus Calmette-Guérin and Mycobacterium smegmatis expressing BfpA and intimin as vaccine vectors against enteropathogenic Escherichia coli.
Vasconcellos HL; Scaramuzzi K; Nascimento IP; Da Costa Ferreira JM; Abe CM; Piazza RM; Kipnis A; Dias da Silva W
Vaccine; 2012 Sep; 30(41):5999-6005. PubMed ID: 22828590
[TBL] [Abstract][Full Text] [Related]
12. [Construction of Escherichia coli-Mycobacteria shuttle plasmid and the stable expression of human interleukin-2 in BCG and Escherichia coli].
Zeng X; Yang M; Qi X
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):336-9. PubMed ID: 10374441
[TBL] [Abstract][Full Text] [Related]
13. A new site-specific integration system for mycobacteria.
Murry J; Sassetti CM; Moreira J; Lane J; Rubin EJ
Tuberculosis (Edinb); 2005; 85(5-6):317-23. PubMed ID: 16256438
[TBL] [Abstract][Full Text] [Related]
14. Development of genetic systems for the mycobacteria.
Jacobs WR; Snapper SB; Lugosi L; Jekkel A; Melton RE; Kieser T; Bloom BR
Acta Leprol; 1989; 7 Suppl 1():203-7. PubMed ID: 2503991
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of cell-mediated immune response in mice by whole HIV-1 gag in Mycobacterium bovis BCG as a live vaccine candidate.
Promkhatkaew D; Pinyosukhee N; Thongdeejaroen W; Sutthent R; Sawanpanyalert P; Warachit P
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):113-22. PubMed ID: 19323043
[TBL] [Abstract][Full Text] [Related]
16. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
[TBL] [Abstract][Full Text] [Related]
17. Perspectives and limitations of the mycobacterial expression system.
Villar C; Benítez J
Arch Med Res; 1994; 25(4):451-3. PubMed ID: 7858406
[TBL] [Abstract][Full Text] [Related]
18. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
Promkhatkaew D; Matsuo K; Pinyosukhee N; Thongdeejaroen W; Leang-Aramgul P; Sawanpanyalert P; Warachit P
Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):273-81. PubMed ID: 19323012
[TBL] [Abstract][Full Text] [Related]
19. [Establishment of a host-vector system in Mycobacterium bovis BCG].
Mizuguchi Y; Taniguchi H; Udou T; Qin MH; Goto Y; Tokunaga T
Kekkaku; 1991 Sep; 66(9):607-13. PubMed ID: 1942732
[TBL] [Abstract][Full Text] [Related]
20. Construction of an unmarked recombinant BCG expressing a pertussis antigen by auxotrophic complementation: protection against Bordetella pertussis challenge in neonates.
Nascimento IP; Dias WO; Quintilio W; Hsu T; Jacobs WR; Leite LC
Vaccine; 2009 Dec; 27(52):7346-51. PubMed ID: 19782111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
